Coronavirus Disease 2019 (COVID-19) World

World Health
Health
Coronavirus Disease
Coronavirus Disease 20192019 (COVID-19)
(COVID-19) Organization
Organization
SituationReport
Situation Report--750 Indonesia
Indonesia

7 AprilData
2021as of 07 May 2020

HIGHLIGHTS

• As of 7 April, the Government of Indonesia reported

1 547 376 (4860 new) confirmed cases of COVID-19, 42 064
(87 new) deaths and 1 391 742 recovered cases from 510
districts across all 34 provinces.1

• To strengthen Indonesia’s capacity for health security, WHO

continues to support the Ministry of Health in the
development of the national influenza pandemic contingency
plan. Consultation meetings with multiple sectors were
conducted on 31 March and 1 April (page 16).

• WHO presented on ‘Emerging Diseases Affecting Global

Health and Future Challenges of the Healthcare System’ in
a virtual lecture hosted by Gadjah Mada University,
Yogyakarta (page 17).

Fig. 1. Geographic distribution of cumulative number of confirmed COVID-19 cases in Indonesia across
the provinces reported from 1 to 7 April 2021. Source of data

Disclaimer: The number of cases reported daily is not equivalent to the number of persons who contracted
COVID-19 on that day; reporting of laboratory-confirmed results may take up to one week from the time of testing.

1
https://covid19.go.id/peta-sebaran-covid19
1
WHO Indonesia Situation Report - 50
who.int/indonesia
 GENERAL UPDATES

• On 4 April, the Ministry of Health (MoH) reported that the E484K strain of the
SARS-CoV-2 virus had been detected in Indonesia. The Eijkman Institute for
Molecular Biology traced the strain of the virus to an individual in Jakarta in
February. The Government will intensify its whole genome sequencing efforts to
strengthen the COVID-19 response in the country. In addition, MoH urged the
public to remain vigilant and strictly comply to the health protocols to curb
transmission of the E484K and other strains of the virus.2

• On 1 April, the MoH Director of Disease Prevention and Control stated that the
start of the third phase of the national COVID-19 vaccination campaign has been
postponed from April to June due to the limited vaccine stock and delays in the
shipment of AstraZeneca vaccines from the COVAX Facility.3 On 5 April, the
Minister of Health stated that the current roll-out of COVID-19 vaccination will be
prioritized to older people (above 60 years old) due to the limited vaccine stock in
country4.

• During a press conference on 30 March, the Coordinating Minister for Human

Development and Cultural Affairs reported that he had signed a joint ministerial
decree together with the Minister of Education, Minister of Religious Affairs,
Minister of Home Affairs and Minister of Health to allow limited face-to-face
learning for the 2021-2022 school year. On the same occasion, the Minister of
Education advised provincial governments to take the necessary preparatory steps
to ensure safety precautions and measures are in place before the start of the new
academic year in July.5

2
https://go.kompas.com/read/2021/04/06/014528974/e484k-covid-19-strain-detected-in-
indonesia?page=all#page2
3
https://nasional.kompas.com/read/2021/04/01/08062301/tak-jadi-april-vaksinasi-covid-19-tahap-ketiga-dimulai-
juni-2021
4
https://nasional.kompas.com/read/2021/04/05/18530121/stok-vaksin-terbatas-vaksinasi-bulan-april-
diprioritaskan-untuk-lansia
5
https://go.kompas.com/read/2021/03/31/032834474/indonesia-allows-limited-face-to-face-classes-for-2021-
2022-academic-year
2
WHO Indonesia Situation Report - 50
who.int/indonesia
 SURVEILLANCE

• On 7 April, 4860 new and 1 547 376 cumulative confirmed COVID-19 cases were
reported nationwide (Fig. 2). The average for the last seven days from 1 to 7 April
was 5095 cases per day, compared to 5037 cases per day reported in the previous
week.

16000 1800000

14000 1600000

12000 1400000

Cumulative number
1200000
Daily number

10000
1000000
8000
800000
6000
600000
4000 400000
2000 200000
0 0
8-Jul
3-Apr

6-Jun

9-Aug

16-Jan
2-Mar

5-May

10-Sep
26-Sep

17-Feb

6-Apr
5-Mar
1-Feb
19-Apr

22-Jun

24-Jul
18-Mar

21-May

25-Aug

13-Nov
29-Nov

21-Mar
12-Oct
28-Oct

15-Dec
31-Dec

Daily number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Fig. 2. Daily and cumulative number of cases reported in Indonesia, as of 7 April 2021. Source of data

Disclaimer: The number of cases reported daily is not the number of persons who contracted
COVID-19 on that day and might be influenced by the number of people tested on that day (see Fig. 17);
reporting of laboratory-confirmed results may take up to one week from the time of testing. Therefore,
caution must be taken in interpreting this figure and the epidemiological curve for further analysis, either
at the national or subnational level.

3
WHO Indonesia Situation Report - 50
who.int/indonesia
 • During the week of 29 March to 4 April, the provinces of Banten and Bengkulu
experienced an increase in the number of weekly cases of more than 50%
compared to the previous week (Fig. 3). It is critical to investigate reasons for the
increase in the new confirmed cases to guide decisions on response activities and
inform the adjustment of public health and social measures (PHSM).6

Banten
Bengkulu
South Sulawesi
West Sulawesi
Riau
Southeast Sulawesi
South Kalimantan
West Kalimantan
Jambi
South Sumatra
Lampung
West Sumatra
Bali
Gorontalo
Central Java
Bangka Belitung Islands
DI Yogyakarta
West Nusa Tenggara
Riau Islands
East Java
East Nusa Tenggara
North Sumatra
East Kalimantan
West Java
West Papua
Aceh
Central Kalimantan
DKI Jakarta
North Maluku
Central Sulawesi
North Kalimantan
Papua
North Sulawesi
Maluku
-100% 0% 100% 200% 300% 400% 500%
Percentage change of weekly number of confirmed cases

Fig. 3. Percentage change of weekly number of confirmed cases by province during 29 March to 4
April 2021 compared to the previous week. Source of data

Disclaimer: The number of weekly confirmed cases is calculated taking into consideration the daily
number of reported cases. Caution should be exercised when interpreting this figure due to data
limitations reported by MoH.

6
It is also important to conduct further investigation if there is a substantial decrease in new cases, especially in
provinces with 50% or more decline. Other indicators, such as testing and contact tracing, may help elucidate the
reasons behind a drop in new cases.
4
WHO Indonesia Situation Report - 50
who.int/indonesia
 • During the week of 29 March to 4 April, the incidence7 of COVID-19 in Indonesia
was 13.7 per 100 000 population, compared to 14.4 per 100 000 in the previous
week (Fig. 4).
35

30

CT2 (20 - <50)

25
Case incidence

20

15

CT1 (<20)
10

0
15/06 - 21/06

28/09 - 04/10

25/01 - 31/01
13/04 - 19/04
20/04 - 26/04
27/04 - 03/05
04/05 - 10/05
11/05 - 17/05
18/05 - 24/05
25/05 - 31/05
01/06 - 07/06
08/06 - 14/06

22/06 - 28/06
29/06 - 05/07
06/07 - 12/07
13/07 - 19/07
20/07 - 26/07
27/07 - 02/08
03/08 - 09/08
10/08 - 16/08
17/08 - 23/08
24/08 - 30/08
31/08 - 06/09
07/09 - 13/09
14/09 - 20/09
21/09 - 27/09

05/10 - 11/10
12/10 - 18/10
19/10 - 25/10
26/10 - 01/11
02/11 - 08/11
09/11 - 15/11
16/11 - 22/11
23/11 - 29/11
30/11 - 06/12
07/12 - 13/12
14/12 - 20/12
21/12 - 27/12
28/12 - 03/01
04/01 - 10/01
11/01 - 17/01
18/01 - 24/01

01/02 - 07/02
08/02 - 14/02
15/02 - 21/02
22/02 - 28/02
01/03 - 07/03
08/03 - 14/03
15/03 - 21/03
22/03 - 28/03
29/03 - 04/04
Fig. 4. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period
reported in Indonesia from 13 April 2020 (when Indonesia first reported community transmission in
the country) to 4 April 2021, classified by level of community transmission (CT): CT1: low incidence;
CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

Disclaimer: There are seven categories for transmission classification: (1) no (active) cases; (2)
imported/sporadic cases; (3) cluster of cases; (4) community transmission 1 (CT1); (5) community
transmission 2 (CT2); (6) community transmission 3 (CT3); and (7) community transmission 4
(CT4).
Caution should be exercised when interpreting this indicator due to limitations listed in the
WHO interim guidance. Other limitations include data incompleteness and data quality issues
reported by MoH. Other epidemiological indicators also need to be evaluated to decide on the level
of community transmission. This disclaimer applies to indicators at national (Fig. 4) and subnational
levels (Figs. 5 to 11).

7
Weekly incidence of COVID-19 is calculated as the number of new cases per 100 000 population per
week averaged over a two-week period. Source of population data
5
WHO Indonesia Situation Report - 50
who.int/indonesia
 • During the week of 29 March to 4 April, the incidence of COVID-19 per 100 000
population was 83.5 in DKI Jakarta, which corresponds to community transmission
level 3 (Fig. 5). Based on WHO interim guidance, community transmission level 3
means that there is a high risk of COVID-19 infection for the general population
and that a high incidence of locally acquired, widely dispersed cases was detected
in the past 14 days.

DKI Jakarta
East Kalimantan
Bangka Belitung Islands
South Kalimantan
North Kalimantan
DI Yogyakarta
Central Kalimantan
Bali
Banten
West Papua
West Java
Riau
Papua
West Sumatra
East Nusa Tenggara
Central Java
Central Sulawesi
Riau Islands
Gorontalo
Bengkulu
Jambi
South Sumatra
South Sulawesi
East Java
West Kalimantan
West Nusa Tenggara
Maluku
Lampung
North Sumatra
North Maluku
North Sulawesi
Southeast Sulawesi
Aceh
West Sulawesi
0.0 50.0 100.0 150.0
Weekly case incidence

CT 1 (<20) CT 2 (20-<50) CT 3 (50 - <150) CT 4 (150+)

Fig. 5. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period
by province in Indonesia during 29 March to 4 April 2021, classified by level of community
transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very
high incidence. Source of data

6
WHO Indonesia Situation Report - 50
who.int/indonesia
 Case incidence Case incidence

15
20
25
30
35
40
45

10

0
5
40
80

0
120
160
200
240
•

13/04 - 19/04 13/04 - 19/04

20/04 - 26/04 20/04 - 26/04
27/04 - 03/05 27/04 - 03/05
04/05 - 10/05 04/05 - 10/05
11/05 - 17/05 11/05 - 17/05

who.int/indonesia
18/05 - 24/05 18/05 - 24/05
25/05 - 31/05 25/05 - 31/05

Source of data

Source of data
01/06 - 07/06 01/06 - 07/06

CT1 (<20)
CT4 (150+)
08/06 - 14/06 08/06 - 14/06

CT 1 (<20)
15/06 - 21/06 15/06 - 21/06

CT2 (20 - <50)

CT3 (50 - <150)

CT 2 (20 - <50)
22/06 - 28/06 22/06 - 28/06
29/06 - 05/07 29/06 - 05/07
06/07 - 12/07 06/07 - 12/07
13/07 - 19/07 13/07 - 19/07
20/07 - 26/07

WHO Indonesia Situation Report - 50

20/07 - 26/07
27/07 - 02/08 27/07 - 02/08
03/08 - 09/08 03/08 - 09/08
10/08 - 16/08 10/08 - 16/08
17/08 - 23/08 17/08 - 23/08
24/08 - 30/08 24/08 - 30/08
to the previous week (Fig. 6 to 11).

31/08 - 06/09 31/08 - 06/09

07/09 - 13/09 07/09 - 13/09
14/09 - 20/09 14/09 - 20/09
21/09 - 27/09 21/09 - 27/09
28/09 - 04/10 28/09 - 04/10
05/10 - 11/10
DKI Jakarta

05/10 - 11/10

West Java
12/10 - 18/10 12/10 - 18/10
19/10 - 25/10 19/10 - 25/10
26/10 - 01/11 26/10 - 01/11
02/11 - 08/11 02/11 - 08/11
09/11 - 15/11 09/11 - 15/11
16/11 - 22/11 16/11 - 22/11
23/11 - 29/11 23/11 - 29/11
30/11 - 06/12 30/11 - 06/12
07/12 - 13/12 07/12 - 13/12
14/12 - 20/12 14/12 - 20/12
21/12 - 27/12 21/12 - 27/12
28/12 - 03/01 28/12 - 03/01
04/01 - 10/01 04/01 - 10/01
11/01 - 17/01 11/01 - 17/01
18/01 - 24/01 18/01 - 24/01
25/01 - 31/01 25/01 - 31/01
01/02 - 07/02 01/02 - 07/02
08/02 - 14/02 08/02 - 14/02
15/02 - 21/02 15/02 - 21/02
22/02 - 28/02 22/02 - 28/02
01/03 - 07/03
The weekly incidence of COVID-19 decreased in all provinces in Java Island
except DI Yogyakarta and Banten during the week of 29 March to 4 April compared

7
01/03 - 07/03
08/03 - 14/03 08/03 - 14/03
15/03 - 21/03 15/03 - 21/03
22/03 - 28/03
22/03 - 28/03
29/03 - 04/04
in DKI Jakarta, from 13 April 2020 to 4 April 2021, classified by level of community transmission
(CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence.
Fig. 6. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period

in West Java, from 13 April 2020 to 4 April 2021, classified by level of community transmission (CT):

(CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence.
in West Java, from 13 April 2020 to 24 January 2021, classified by level of community transmission
Fig. 6. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period
CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence.
Fig. 7. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period
29/03 - 04/04
 Case incidence
Case incidence

10
15
20
25
30
35
40

0
5

10
30
40
50
60

20
70

0
13/04 - 19/04
13/04 - 19/04 20/04 - 26/04
20/04 - 26/04 27/04 - 03/05
27/04 - 03/05 04/05 - 10/05
04/05 - 10/05 11/05 - 17/05
11/05 - 17/05

who.int/indonesia
18/05 - 24/05
18/05 - 24/05 25/05 - 31/05
25/05 - 31/05

Source of data
01/06 - 07/06

Source of data
01/06 - 07/06 08/06 - 14/06

CT 1 (<20)
08/06 - 14/06

CT 1 (<20)
15/06 - 21/06
15/06 - 21/06
CT 2 (20 - <50)

22/06 - 28/06

CT 2 (20 - <50)
22/06 - 28/06 29/06 - 05/07

CT 3 (50 - <150)
29/06 - 05/07 06/07 - 12/07
06/07 - 12/07 13/07 - 19/07
13/07 - 19/07 20/07 - 26/07

WHO Indonesia Situation Report - 50

20/07 - 26/07 27/07 - 02/08
27/07 - 02/08 03/08 - 09/08
03/08 - 09/08 10/08 - 16/08
10/08 - 16/08 17/08 - 23/08
17/08 - 23/08 24/08 - 30/08
24/08 - 30/08 31/08 - 06/09
31/08 - 06/09 07/09 - 13/09
07/09 - 13/09 14/09 - 20/09
14/09 - 20/09 21/09 - 27/09
21/09 - 27/09 28/09 - 04/10
28/09 - 04/10 05/10 - 11/10
05/10 - 11/10
Central Java

12/10 - 18/10
12/10 - 18/10

DI Yogyakarta
19/10 - 25/10
19/10 - 25/10 26/10 - 01/11
26/10 - 01/11 02/11 - 08/11
02/11 - 08/11 09/11 - 15/11
09/11 - 15/11 16/11 - 22/11
16/11 - 22/11 23/11 - 29/11
23/11 - 29/11 30/11 - 06/12
30/11 - 06/12 07/12 - 13/12
07/12 - 13/12 14/12 - 20/12
14/12 - 20/12 21/12 - 27/12
21/12 - 27/12 28/12 - 03/01
28/12 - 03/01 04/01 - 10/01
04/01 - 10/01 11/01 - 17/01
11/01 - 17/01 18/01 - 24/01
18/01 - 24/01 25/01 - 31/01
25/01 - 31/01 01/02 - 07/02
01/02 - 07/02 08/02 - 14/02
08/02 - 14/02 15/02 - 21/02
15/02 - 21/02 22/02 - 28/02
22/02 - 28/02 01/03 - 07/03

8
01/03 - 07/03 08/03 - 14/03
08/03 - 14/03 15/03 - 21/03
15/03 - 21/03 22/03 - 28/03
22/03 - 28/03
in Central Java, from 13 April 2020 to 4 April 2021, classified by level of community transmission
(CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence.
Fig. 8. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period

29/03 - 04/04

in DI Yogyakarta, from 13 April 2020 to 4 April 2021, classified by level of community transmission
(CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence.
Fig. 9. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period
29/03 - 04/04
 Case incidence Case incidence

10
15
20
25
10
12
14
16
18
20

0
5
0
2
4
6
8
13/04 - 19/04 13/04 - 19/04
20/04 - 26/04 20/04 - 26/04
27/04 - 03/05 27/04 - 03/05
04/05 - 10/05 04/05 - 10/05
11/05 - 17/05 11/05 - 17/05

who.int/indonesia
18/05 - 24/05 18/05 - 24/05
25/05 - 31/05 25/05 - 31/05

Source of data
Source of data
01/06 - 07/06 01/06 - 07/06
08/06 - 14/06

CT 1 (<20)
CT 1 (<20)
08/06 - 14/06
15/06 - 21/06 15/06 - 21/06

CT 2 (20 - <50)
22/06 - 28/06 22/06 - 28/06
29/06 - 05/07 29/06 - 05/07
06/07 - 12/07 06/07 - 12/07
13/07 - 19/07 13/07 - 19/07

WHO Indonesia Situation Report - 50

20/07 - 26/07 20/07 - 26/07
27/07 - 02/08 27/07 - 02/08
03/08 - 09/08 03/08 - 09/08
10/08 - 16/08 10/08 - 16/08
17/08 - 23/08 17/08 - 23/08
24/08 - 30/08 24/08 - 30/08
31/08 - 06/09 31/08 - 06/09
07/09 - 13/09 07/09 - 13/09
14/09 - 20/09 14/09 - 20/09
21/09 - 27/09 21/09 - 27/09
28/09 - 04/10 28/09 - 04/10

Banten
East Java

05/10 - 11/10 05/10 - 11/10

12/10 - 18/10 12/10 - 18/10
19/10 - 25/10 19/10 - 25/10
26/10 - 01/11 26/10 - 01/11
02/11 - 08/11 02/11 - 08/11
09/11 - 15/11 09/11 - 15/11
16/11 - 22/11 16/11 - 22/11
23/11 - 29/11 23/11 - 29/11
30/11 - 06/12 30/11 - 06/12
07/12 - 13/12 07/12 - 13/12
14/12 - 20/12 14/12 - 20/12
21/12 - 27/12 21/12 - 27/12
28/12 - 03/01 28/12 - 03/01
04/01 - 10/01 04/01 - 10/01
11/01 - 17/01 11/01 - 17/01
18/01 - 24/01 18/01 - 24/01
25/01 - 31/01 25/01 - 31/01
01/02 - 07/02 01/02 - 07/02
08/02 - 14/02 08/02 - 14/02
15/02 - 21/02 15/02 - 21/02
22/02 - 28/02 22/02 - 28/02

9
01/03 - 07/03 01/03 - 07/03
08/03 - 14/03 08/03 - 14/03
15/03 - 21/03 15/03 - 21/03
22/03 - 28/03 22/03 - 28/03

in Banten, from 13 April 2020 to 4 April 2021, classified by level of community transmission (CT):
CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence.
Fig. 11. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period
29/03 - 04/04 29/03 - 04/04
in East Java, from 13 April 2020 to 4 April 2021, classified by level of community transmission (CT):
CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence.
Fig. 10. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period
 • Test positivity proportion nationwide increased sharply after 23 November and
reached a peak of 30.5% in mid-February. Subsequently, the positivity proportion
declined and stood at 12.3% on 4 April (Fig. 12). However, the percentage of positive
samples can be interpreted reliably only with comprehensive surveillance and
testing in the order of one person tested per 1000 population per week. This
minimum case detection benchmark was achieved in DKI Jakarta, DI Yogyakarta,
and Banten for the last three weeks, but none of these provinces had a test positivity
proportion of less than 5% (Fig. 13).

40%

35%
CT 4 (20%+)
30%
Positivity proportion (%)

25%

20%

CT 3 (5% - <20%)
15%

10%

5%
CT 2 (2% - <5%)

CT 1 (<2%)
0%
1-May 1-Jun 1-Jul 1-Aug 1-Sep 1-Oct 1-Nov 1-Dec 1-Jan 1-Feb 1-Mar 1-Apr

Fig. 12. Test positivity proportion averaged over a two-week period at the national level in
Indonesia, as of 4 April 2021, classified by level of community transmission (CT): CT1: low
incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of
data
Disclaimer: Caution should be exercised when interpreting this indicator due to limitations listed
in the WHO interim guidance. Other epidemiological indicators also need to be evaluated to
determine the level of community transmission.

10
WHO Indonesia Situation Report - 50
who.int/indonesia
 8.00 55.0%
People tested/1000 population/week

50.0%
7.00
45.0%

Positivity proportion (%)

6.00 40.0%
5.00 35.0%
30.0%
4.00
25.0%
3.00 20.0%
2.00 15.0%
10.0%
1.00
5.0%
- 0.0%
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3
Indonesia DKI West Central DI Yogyakarta East Banten
Jakarta Java Java Java

People tested/1000 population/week Test positivity proportion

8.00 55.0%
People tested/1000 population/week

50.0%
7.00
45.0%

Positivity proportion (%)

6.00 40.0%
5.00 35.0%
30.0%
4.00
25.0%
3.00 20.0%
2.00 15.0%
10.0%
1.00
5.0%
- 0.0%
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3
Indonesia West East West Riau Central South Southeast
Sumatra Kalimantan Papua Kalimantan Sumatra Sulawesi

People tested/1000 population/week Test positivity proportion

Fig. 13. Test positivity proportion and people tested per 1000 population per week at the national
level and in select provinces.

Week 1: 15/03/21 to 21/03/21; Week 2: 22/03/21 to 28/03/21; Week 3: 29/03/21 to 04/04/21

Benchmark: one person tested per 1000 population per week
Threshold test positivity proportion: <5%
Source of data: Indonesia, DKI Jakarta, West Java, Central Java, DI Yogyakarta, East Java,
Banten, West Sumatra, East Kalimantan, West Papua, Riau, Central Kalimantan, South Sumatra,
Southeast Sulawesi

Note: Due to a limitation in data, other provinces could not be evaluated. For surveillance purposes, test
positivity proportion is calculated as the number of confirmed cases divided by the number of people
tested for diagnosis.

11
WHO Indonesia Situation Report - 50
who.int/indonesia
 • During the week of 29 March to 4 April, Bali had the highest weekly number of
confirmed COVID-19 deaths per 100 000 population, followed by East Kalimantan,
DKI Jakarta, DI Yogyakarta, and Bangka Belitung Islands (Fig. 14).
Bali
East Kalimantan
DKI Jakarta
DI Yogyakarta
Bangka Belitung Islands
North Kalimantan
Banten
South Kalimantan
East Java
Central Sulawesi
West Java
Riau
Central Java
Central Kalimantan
Lampung
East Nusa Tenggara
Gorontalo
West Papua
South Sumatra
West Sumatra
Riau Islands
Bengkulu
West Nusa Tenggara
West Sulawesi
North Sumatra
Aceh
Jambi
Papua
North Maluku
South Sulawesi
Southeast Sulawesi
North Sulawesi
Maluku
West Kalimantan
0.0 0.2 0.4 0.6 0.8 1.0 1.2
Weekly number of confirmed COVID-19 deaths per 100 000 population

CT 1 (<1) CT 2 (1 - <2) CT 3 (2 - <5) CT 4 (5+)

Fig. 14. Number of confirmed COVID-19 deaths per 100 000 population per week averaged over a
two-week period by province in Indonesia during 29 March to 4 April 2021, classified by level of community
transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high
incidence. Source of data

Disclaimer: Based on data availability, only confirmed COVID-19 deaths have been included. As per
WHO definition, however, death resulting from a clinically compatible illness in a probable or confirmed
COVID-19 case is a COVID-19-related death, unless there is a clear alternative cause of death that cannot
be related to COVID-19 (e.g. trauma); there should be no period of complete recovery between the illness
and death.
12
WHO Indonesia Situation Report - 50
who.int/indonesia
 • During the week of 29 March to 4 April, the number of confirmed COVID-19 deaths
was 0.36 per 100 000 population8, compared to 0.38 per 100 000 in the previous
week (Fig. 15).

0.8

0.7
Deaths per 100 000 population

0.6

0.5

0.4

0.3

0.2

0.1

0.0
13/04 - 19/04

18/05 - 24/05

23/11 - 29/11

28/12 - 03/01

01/02 - 07/02
20/04 - 26/04
27/04 - 03/05
04/05 - 10/05
11/05 - 17/05

25/05 - 31/05
01/06 - 07/06
08/06 - 14/06
15/06 - 21/06
22/06 - 28/06
29/06 - 05/07
06/07 - 12/07
13/07 - 19/07
20/07 - 26/07
27/07 - 02/08
03/08 - 09/08
10/08 - 16/08
17/08 - 23/08
24/08 - 30/08
31/08 - 06/09
07/09 - 13/09
14/09 - 20/09
21/09 - 27/09
28/09 - 04/10
05/10 - 11/10
12/10 - 18/10
19/10 - 25/10
26/10 - 01/11
02/11 - 08/11
09/11 - 15/11
16/11 - 22/11

30/11 - 06/12
07/12 - 13/12
14/12 - 20/12
21/12 - 27/12

04/01 - 10/01
11/01 - 17/01
18/01 - 24/01
25/01 - 31/01

08/02 - 14/02
15/02 - 21/02
22/02 - 28/02
01/03 - 07/03
08/03 - 14/03
15/03 - 21/03
22/03 - 28/03
29/03 - 04/04
Fig. 15. Number of confirmed COVID-19 deaths per 100 000 population per week averaged over a
two-week period in Indonesia, as of 4 April 2021. Source of data

Disclaimer: Based on data availability, only confirmed COVID-19 deaths have been included. As
per WHO definition, however, death resulting from a clinically compatible illness in a probable or
confirmed COVID-19 case is a COVID-19-related death, unless there is a clear alternative cause
of death that cannot be related to COVID-19 (e.g. trauma); there should be no period of complete
recovery between the illness and death. Evaluation of the level of community transmission could
not be conducted due to data limitations.

• Out of six provinces in Java, only DKI Jakarta and Banten showed a consecutive
decline over the last three weeks in the number of deaths in confirmed and probable
cases (Fig. 16).

8
Weekly mortality of COVID-19 is calculated as the number of COVID-19 deaths per 100 000 population per week
averaged over a two-week period. Source of population data
13
WHO Indonesia Situation Report - 50
who.int/indonesia
 400 DKI Jakarta 300 West Java

300 45
200 6
200 171 142
100 218 17
122 197
100
134 144 109
56
0 0
15/03/2021 - 21/03/2021 - 29/03/2021 - 15/03/2021 - 21/03/2021 - 29/03/2021 -
21/03/2021 28/03/2021 04/04/2021 21/03/2021 28/03/2021 04/04/2021

Deaths in confirmed cases Deaths in probable cases Deaths in confirmed cases Deaths in probable cases

Central Java 40
DI Yogyakarta
300

30
200
287 20 37
233 28 32
100 193
10

0 0
15/03/2021 - 21/03/2021 - 29/03/2021 - 15/03/2021 - 21/03/2021 - 29/03/2021 -
21/03/2021 28/03/2021 04/04/2021 21/03/2021 28/03/2021 04/04/2021

Deaths in confirmed cases Deaths in confirmed cases

250 East Java 50 Banten

200 9 40 1
2
13 30
150
2
100 197 20 38
160 186
50 10 24 19
0 0
15/03/2021 - 21/03/2021 - 29/03/2021 - 15/03/2021 - 21/03/2021 - 29/03/2021 -
21/03/2021 28/03/2021 04/04/2021 21/03/2021 28/03/2021 04/04/2021

Deaths in confirmed cases Deaths in probable cases Deaths in confirmed cases Deaths in probable cases

Fig. 16. Deaths among confirmed COVID-19 cases and probable cases per week over three weeks between
15 March to 4 April 2021 in Java. Source of data: DKI Jakarta, West Java, Central Java, DI Yogyakarta,
East Java, Banten

Disclaimer: The data are provisional. There may be a discrepancy in the number of deaths in confirmed
COVID-19 cases between national and provincial data sources.

14
WHO Indonesia Situation Report - 50
who.int/indonesia
 HEALTH OPERATIONS

• As reported on 7 April, the daily number of people tested for COVID-19 was 53 457
and the cumulative number of people tested was 8 798 525 (Fig. 17).

80000 10000000
70000 9000000
8000000

Cumulative number
60000
7000000
Daily number

50000 6000000
40000 5000000
30000 4000000
3000000
20000
2000000
10000 1000000
0 0
4-Apr

8-Aug

3-Apr
7-Mar

2-May

19-Sep
3-Oct

20-Feb
6-Mar
5-Sep

23-Jan
6-Feb
14-Nov
28-Nov

9-Jan
21-Mar

18-Apr

16-May
30-May

11-Jul
25-Jul

12-Dec
26-Dec

20-Mar
13-Jun
27-Jun

22-Aug

17-Oct
31-Oct
Daily number of people tested Cumulative number of people tested
Fig. 17. Daily and cumulative number of people tested for COVID-19 in Indonesia,
as of 7 April 2021. Source of data

• As of 7 April, the proportion of people recovered among the total confirmed

COVID-19 cases was 89.9% and there were 113 570 active cases (Fig. 18).
200000 100.0
180000 90.0
160000 80.0

Percentage (%)
140000 70.0
Number

120000 60.0
100000 50.0
80000 40.0
60000 30.0
40000 20.0
20000 10.0
0 0.0
3-May

6-Jul
1-Apr

4-Jun

7-Aug

8-Sep
24-Sep

15-Feb

4-Apr
14-Jan
30-Jan

3-Mar
13-Dec
29-Dec
17-Apr

19-May

20-Jun

22-Jul

23-Aug

10-Oct
26-Oct
11-Nov
27-Nov

19-Mar

Active cases Recovery percentage

Fig. 18. Number of active cases of COVID-19 and recovery percentage in Indonesia,
as of 7 April 2021. Source of data

15
WHO Indonesia Situation Report - 50
who.int/indonesia
 • The reported number of confirmed COVID-19 cases hospitalized in DKI Jakarta
reached a peak of 9888 hospitalized cases on 12 February. The number of
hospitalized cases has since decreased to 3392 on 4 April (Fig. 19).
12000
Number of confirmed COVID-19

10000
cases hospitalized

8000

6000

4000

2000

0
1-Aug

5-Mar
5-Nov
6-Sep
18-Sep
30-Sep

16-Jan
28-Jan
9-Feb
21-Feb
11-Dec
23-Dec
13-Aug
25-Aug

12-Oct
24-Oct

17-Nov
29-Nov

4-Jan

17-Mar
29-Mar
Fig. 19. Number of confirmed COVID-19 cases hospitalized in DKI Jakarta from 1 August 2020
to 4 April 2021. Source of data

Disclaimer: Data from Wisma Atlet are not included.

RISK COMMUNICATION

• WHO is regularly translating and sharing important health messages on its website
and social media platforms – Twitter and Instagram – and continues to publish
infographics useful for the public.

RISK AND NEEDS ASSESSMENT, AND PLANNING

• WHO continues to provide technical assistance to MoH to develop the national

influenza pandemic contingency plan to strengthen Indonesia’s capacity for health
security. Virtual consultation meetings involving multiple sectors were conducted
on 31 March and 1 April, attended by over 85 participants including representatives
from the National Board for Disaster Management (Badan Nasional
Penanggulangan Bencana (BNPB)), Ministry of Agriculture, Coordinating Ministry
for Human Development and Cultural Affairs and the National Army. During the
meetings, WHO highlighted the importance of including a contingency plan as part
of a comprehensive preparedness and response cycle.
16
WHO Indonesia Situation Report - 50
who.int/indonesia
 • On 30 March, WHO presented on ‘Emerging Diseases Affecting Global Health and
Future Challenges of the Healthcare System’ in a virtual lecture hosted by Gadjah
Mada University of Yogyakarta. Around 165 medical students from the university
participated in the session. WHO highlighted COVID-19 and other emerging
infectious diseases (EID) as well as International Health Regulations (IHR) core
capacities and COVID-19 strategic response plan.

Fig. 20. WHO presented on ‘Emerging Diseases Affecting Global Health and Future
Challenges of the Healthcare System’ in a virtual lecture hosted by Gadjah Mada
University, on 30 March 2021. Credit: WHO/Endang Wulandari

VACCINATION

• As of 5 April, 13 087 173 vaccine doses have been administered to health workers,
essential public service workers and older people (above 60 years old) in the
national COVID-19 vaccination campaign; 8 856 373 people have received the
first dose and 4 230 800 people have received the second dose (Fig. 21).

17
WHO Indonesia Situation Report - 50
who.int/indonesia
 14000000
12000000
Number vaccinated

10000000
8000000
6000000
4000000
2000000
0 1-Feb
3-Feb
5-Feb
7-Feb
9-Feb

15-Feb
11-Feb
13-Feb

17-Feb
19-Feb
21-Feb
23-Feb
25-Feb
27-Feb
1-Mar
3-Mar
5-Mar
7-Mar
9-Mar
11-Mar
13-Mar
15-Mar
17-Mar
19-Mar
21-Mar
23-Mar
25-Mar
27-Mar
29-Mar
31-Mar
2-Apr
4-Apr
22-Jan
24-Jan
26-Jan
28-Jan
30-Jan

Cumulative 1st dose vaccination Cumulative 2nd dose vaccination

Fig. 21. Cumulative number of vaccine doses administered in Indonesia, from 22 January to
5 April 2021. Source of data

Disclaimer: COVID-19 vaccination started on 13 January. Published data from MoH is available
starting from 22 January.

• As of 5 April, the number of health workers who have received the second dose of
the COVID-19 vaccine (fully vaccinated) was 1 297 351 (88.3% of the target
population of 1 468 764). The number of essential public service workers who have
received the first dose of the vaccine was 5 641 985 (32.6% of the targeted
17 327 169); 2 604 222 (15% of the targeted number) have received the second
dose of the vaccine. The number of older people who have received the first dose
of the vaccine was 1 771 003 (8.2% of the targeted 21 553 118); 329 227 (1.5% of
the targeted number) have received the second dose (Fig. 22).

18
WHO Indonesia Situation Report - 50
who.int/indonesia
 Essential public service 5641985
workers 2604222

1443385
Health workers
1297351

1771003
Older people 1st dose
329227 2nd dose

0 1000000 2000000 3000000 4000000 5000000 6000000

Number of people who have received COVID-19 vaccine

Fig. 22. Cumulative number of people who have received COVID-19 vaccine in Indonesia,
as of 5 April 2021. Source of data

Disclaimer: COVID-19 vaccination started with health workers on 13 January. The second
stage of COVID-19 vaccination started on 17 February, targeting essential public service
workers and older people (above 60 years old). Published data from MoH is available
starting from 22 January.

19
WHO Indonesia Situation Report - 50
who.int/indonesia
 PARTNER COORDINATION

• The overall funding request for WHO operations and technical assistance is
US$ 46 million (US$ 27 million for response and US$ 19 million for recovery
phase), based on estimated needs as of April 2021 (Fig. 23).

Fig. 23. WHO funding situation for COVID-19 response, April 2021.

Data presented in this situation report have been taken from publicly available data from the MoH
(https://infeksiemerging.kemkes.go.id/), COVID-19 Mitigation and National Economic Recovery
Team (KPCPEN) (http://covid19.go.id) and provincial websites. There may be differences in
national and provincial data depending on the source used. All data are provisional and subject to
change.

20
WHO Indonesia Situation Report - 50
who.int/indonesia
RECENT AND UPCOMING WHO RESOURCE MATERIALS

Table 1: Title and details of recent WHO resource materials

Source: https://www.who.int/

Title Details
WHO COVID-19 The Weekly Epidemiological Update provides an overview of
Weekly the global, regional and country-level COVID-19 cases and
Epidemiological deaths, highlighting key data and trends as well as other
Update, 6 April 2021 pertinent epidemiological information concerning the
COVID-19 pandemic. This edition includes data as received by
WHO from national authorities, as of 4 April 2021.

WHO COVID-19 As part of WHO’s response to the COVID-19 pandemic, the

infection prevention WHO Research and Development (R&D) Blueprint was
and control (IPC) activated to improve coordination between scientists and global
pillar - achievements. health professionals, accelerate the research and development
February 2020 - process, and develop new norms and standards to learn from
January 2021 and improve upon the global response. Infection prevention
(meeting report and control (IPC) is one of the pillars of the WHO COVID-19
draft), 6 April 2021 R&D Blueprint, which is supported by a group of international
experts convened by WHO in the COVID-19 IPC R&D Expert
Group. In February 2020 the WHO R&D Blueprint developed a
global research roadmap to accelerate research that can
contribute to containing the spread of the epidemic and to
facilitate receipt of optimal care by those affected. It also
includes detailed knowledge gaps and research priorities
identified by the IPC pillar.

Episode 32 of WHO Assistant Director-General for Access to Medicines and

Science in 5, WHO’s Health Products Dr Mariângela Simao explains the impact of
series of inequity in the fight against COVID-19.
conversations in
science, 1 April 2021
Therapeutics and This fourth version of the WHO Therapeutics and COVID-19:
COVID-19: living living guideline addresses the use of ivermectin in patients with
guideline, COVID-19. It follows the increased international attention on
31 March 2021 ivermectin as a potential therapeutic option. While ivermectin is
also being investigated for prophylaxis, this guideline only
addresses its role in the treatment of COVID-19. The panel
recommendation is not to use ivermectin for the management
of COVID-19 except in the context of a clinical trial. This update
does not include changes for any other drugs in the living
guideline.

21
WHO Indonesia Situation Report - 50
who.int/indonesia
A SNAPSHOT OF WHO COURSES AND INFORMATION MATERIAL
Online WHO COVID-19 courses:
• COVID-19 vaccination training for health workers
• Standard precautions: Environmental cleaning and disinfection
• Management of COVID-19 in long-term care facilities
• Operational planning guidelines and COVID-19
• Clinical management of severe acute respiratory infections
• Health and safety briefing for respiratory diseases – eProtect

WHO guidance:
• WHO-convened global study of origins of
SARS-CoV-2: China Part (joint report)
• Operational considerations to expedite
genomic sequencing component of
GISRS surveillance of SARS-CoV-2
• COVID-19 new variants: Knowledge
gaps and research (draft meeting report)
• Evaluation of COVID-19 vaccine
effectiveness

Infographics:
• Contact tracing
• COVID-19 new variants
• COVID-19 vaccines and vaccination
• The truth about COVID-19 vaccines
• Quarantine and self-monitoring
• COVID-19 tests

Questions and answers:

• COVID-19: Vaccines
• COVID-19: Vaccine research and development
• COVID-19: Vaccine access and allocation
• How are vaccines developed?

Videos:
• Science in 5: Evolution of the SARS-CoV-2 virus
• Time to abide (1-10)
• Hand sanitizer routine
• COVID-19 virus variants

For more information please feel free to contact: seinocomm@who.int

WHO Indonesia Reports

22
WHO Indonesia Situation Report - 50
who.int/indonesia